Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04601272 · ClinicalTrials.gov registry record
Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 240
- Enrollment target
NCT04601272: Completed study, sponsored by Massachusetts General Hospital.
NCT04601272 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 240 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04601272 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
The purpose of this retrospective observational study is to evaluate the performance of the Shared Decision Making Process scale in a sample of patients who have received a decision aid about the decision to screen or not screen for breast cancer, colon cancer, prostate cancer, or lung cancer.
Primary Outcome
The Shared Decision Making Process is a short patient-reported survey that measures the amount of shared decision making that occurs in an interaction. Scores range from 0-4 where higher values indicate a better shared decision making process outcome.
Interventions
- BEHAVIORAL Decision aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2020-09-29 |
| Est. Completion | 2021-06-24 |
What the finished NCT04601272 record still lists
NCT04601272 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Decision aid is the first listed.
NCT04601272 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04601272 about?
NCT04601272 is a clinical study titled "Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions". The purpose of this retrospective observational study is to evaluate the performance of the Shared Decision Making Process scale in a sample of patients who have received a decision aid about the decision to screen or not screen for breast cancer, colon cancer, prostate cancer, or lung cancer.
What is the current status of trial NCT04601272?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2020-09-29. Estimated completion is 2021-06-24.
What interventions are being tested in trial NCT04601272?
The interventions under investigation include: Decision aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT04601272?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI